EGEN is an Alabama-based specialty biopharmaceutical company developing safe and efficient polymeric delivery systems to be used to create products for treatment of human diseases. The Company's delivery vehicles, based on a synthetic biocompatible polymeric system can be used to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking. Unique polymer chemistry and formulation strategies, designed to overcome delivery barriers, are the distinguishing characteristics of EGEN’s proprietary technology, and differ substantially from other approaches.